(Q41026223)

25 September 2017

1 reference

title

Beta-agonists as antiobesity, antidiabetic and nutrient partitioning agents (English)

1 reference

25 September 2017

Yen TT

1

1 reference

25 September 2017

1 November 1995

1 reference

25 September 2017

1 reference

25 September 2017

3 Suppl 4

1 reference

25 September 2017

531S-536S

1 reference

Effect of a beta-adrenergic agonist on glucose transport and insulin-responsive glucose transporters (GLUT4) in brown adipose tissue of control and obese fa/fa rats

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Effect of a novel thermogenic beta-adrenoceptor agonist (BRL 26830) on insulin resistance in soleus muscle from obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

An investigation of the beta-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Beta 3-adrenergic receptor stimulation restores message and expression of brown-fat mitochondrial uncoupling protein in adult dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Tremor and the anti-obesity drug BRL 26830A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

The human beta 3-adrenoceptor: the search for a physiological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Molecular characterization of the human beta 3-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Insulin resistance syndrome: possible key role of blood flow in resting muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

ICI D7114 a novel selective β-adrenoceptor agonist selectively stimulates brown fat and increases whole-body oxygen consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

LY79771: a novel compound for weight control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Elevation of a specific mRNA in longissimus muscle of steers fed ractopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Antiobesity and antidiabetic beta-agonists: lessons learned and questions to be answered

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Effects of a .BETA.3-Adrenoceptor Agonist, BRL 26830A, on Insulin and Glucagon Release in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Brown adipose tissue is a major site of glucose utilisation in C57Bl/6 ob/ob mice treated with a thermogenic beta-adrenoceptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00223.X

10.1002/J.1550-8528.1995.TB00223.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8697054